Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - Cardlytics, Inc. | cdlxform10-k2019ex321.htm |
| EX-31.2 - EXHIBIT 31.2 - Cardlytics, Inc. | cdlxform10-k2019ex312.htm |
| EX-31.1 - EXHIBIT 31.1 - Cardlytics, Inc. | cdlxform10-k2019ex311.htm |
| EX-10.22 - EXHIBIT 10.22 - Cardlytics, Inc. | cdlxform10-k2019ex1022.htm |
| EX-10.21 - EXHIBIT 10.21 - Cardlytics, Inc. | cdlxform10-k2019ex1021.htm |
| EX-4.3 - EXHIBIT 4.3 - Cardlytics, Inc. | cdlxform10-k2019ex43.htm |
| 10-K - 10-K - Cardlytics, Inc. | cdlxform10-k2019.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-222965 and 333-231640 on Form S-8, and Registration Statement No. 333-232861 on Form S-3 of our report dated March 3, 2020, relating to the consolidated financial statements of Cardlytics, Inc. and subsidiaries appearing in this Annual Report on Form 10-K of Cardlytics, Inc. for the year ended December 31, 2019.
/s/ DELOITTE & TOUCHE LLP
Atlanta, Georgia
March 3, 2020